rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OABI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      OmniAb (OABI) Q3 Results Keep Cash Progress In Focus
      Nov 1Yahoo FinanceOABI
      OmniAb Stock: A Self-Funding Option Book On 433 Partner Programs (NASDAQ:OABI)

      OmniAb reaches self-sustaining cash flow as its royalty platform gains traction.

      Nov 1Seeking AlphaOABI
      OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ...
      Oct 31Yahoo FinanceOABI
      OmniAb, Inc. Q3 2026 Earnings Call Summary
      Oct 30Yahoo FinanceOABI
      OmniAb Q3 2026 Earnings Call Transcript
      Oct 30BenzingaOABI
      OmniAb (OABI) Q3 2026 Earnings Call Transcript

      Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

      Oct 30The Globe and MailOABI
      OmniAb Q3 Earnings Call Highlights
      Oct 30Yahoo FinanceOABI
      OmniAb earnings matched, revenue topped estimates
      Oct 30Investing.comOABI
      OmniAb Q3 Loss Narrows, Revenue Rises; 2026 Revenue Outlook Raised; Shares Down Pre-Bell
      Oct 30Yahoo FinanceOABI
      OmniAb, Inc. (OABI) Reports Q3 Loss, Tops Revenue Estimates
      Oct 30Yahoo FinanceOABI
      OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights
      Oct 30Yahoo FinanceOABI
      Earnings To Watch: OmniAb Inc (OABI) Q3 2026 -- GF Value Sees 40% Downside
      Oct 29Yahoo FinanceOABI
      OmniAb to Participate in Upcoming Investor Conferences in November
      Oct 26Yahoo FinanceOABI
      OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference
      Oct 25Yahoo FinanceOABI
      OmniAb at LD Micro main event: royalties, scale and patience
      Oct 20Investing.comOABI
      OmniAb to Report Third Quarter 2026 Financial Results on October 30
      Oct 14Yahoo FinanceOABI
      Leerink Partners Sticks to Its Buy Rating for OmniAb (OABI)

      Detailed price information for Omniab Inc (OABI-Q) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailOABI
      OmniAb Investor Day Spotlights Royalty Pipeline, OmniTides Launch and xPloration Growth
      Oct 7Yahoo FinanceOABI
      StoneX raises OmniAb stock price target to $6 on new products
      Oct 7Investing.comOABI
      Stifel reiterates OmniAb stock rating on technology platform
      Oct 7Investing.comOABI
      OmniAb, Inc. (OABI) Analyst/Investor Day - Slideshow (NASDAQ:OABI) 2026-10-06
      Oct 6Seeking AlphaOABI
      All You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to Buy
      Oct 6Yahoo FinanceOABI
      OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day

      EMERYVILLE, Calif., October 06, 2026--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today hosts its Investor & Analyst Day in Emeryville, CA. With a full presentation agenda, the event highlights recent partner developments, the broader roll out of the xPloration® platform, and introduces the OmniTides™ peptide discovery platform and brand.

      Oct 6Yahoo FinanceOABI
      OmniAb to Host Investor & Analyst Day on October 6, 2026

      EMERYVILLE, Calif., September 14, 2026--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reiterates details of its upcoming Investor & Analyst Day, to be held on October 6, 2026, in Emeryville, CA.

      Sep 14Yahoo FinanceOABI
      Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI?

      On August 17, OmniAb, Inc. (NASDAQ:OABI) announced a global collaboration and license agreement with Eli Lilly and Company (NYSE:LLY) to discover and develop novel ion channel therapeutics. Leveraging OmniAb’s specialized antibody discovery platform, the deal grants Lilly exclusive global rights to commercialize resulting candidates in exchange for an upfront payment, up to $370 million in […]

      Aug 28Yahoo FinanceOABILLY
      OmniAb to Participate in Upcoming Investor Conferences

      EMERYVILLE, Calif., August 26, 2026--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced management’s participation in the following upcoming investor conferences:

      Aug 26Yahoo FinanceOABI

      This is the newest page. Registered accounts read further back.